Atopic eczema is an itchy inflammatory disorder Background: characterised by skin barrier dysfunction. Loss-of-function mutations in the gene encoding filaggrin ( ) are a major risk factor, but the mechanisms FLG by which filaggrin haploinsufficiency leads to atopic inflammation remain incompletely understood. Skin as an organ that can be modelled using primary cells provides the opportunity for selected genetic effects to in vitro be investigated in detail.
Introduction
Atopic eczema (also termed atopic dermatitis or eczema 1, 2 ) is an itchy inflammatory skin disorder with complex and multifactorial aetiology 3 . The phenotype is heterogeneous and pathogenic mechanisms vary between affected individuals 4 . The pathogenesis may include differential contributions of: immune activation and skin barrier dysfunction; local and systemic effects; multiple genetic and environmental factors 5 . Loss-of-function mutations in FLG, encoding filaggrin, cause the common Mendelian disorder of keratinization, ichthyosis vulgaris (OMIM # 146700). FLG null mutations are also strongly associated with increased risk of atopic eczema 6,7 and multiple other atopic traits [8] [9] [10] .
Skin is an organ that can be modelled in vitro to effectively recapitulate the multi-layered structure and gene expression patterns of human skin in vivo 11 . This offers the opportunity for selected molecular mechanisms to be investigated in relative isolation from a complex disease state, using relevant primary cells. Replicate experiments can be performed using primary cells with the same genetic background or cells from different donors 12 . Detailed functional and biochemical analyses may then be applied to define potential therapeutic targets 12, 13 .
Filaggrin is a marker of keratinocyte differentiation; it is expressed in the granular layer of the upper epidermis as a polymer -profilaggrin -which undergoes post-translational modification and stepwise proteolysis to release monomeric filaggrin 14 . Profilaggrin and filaggrin have multiple functions, each of which have been described as contributing to the mechanical, biochemical, immunological and microbiological aspects of skin barrier function 15 . Clinical studies have shown that filaggrin haploinsufficiency is associated with xerosis and ichthyosis (dry and scaly skin), keratosis pilaris (increased keratin within skin follicles), palmar hyperlinearity 16 and increased transepidermal water loss 17 . Transcriptomic analysis of full thickness skin biopsies have shown evidence of an abnormal defence response in FLG haploinsufficient atopic skin 18 ; proteomic analysis to assess the effect of FLG knockdown in an epidermal organoid has also shown features of inflammation and stress protease activity 19 . However, in vitro studies have not shown consistent histological or functional effects of filaggrin deficiency in the various different skin organoid models published to date 20 and the multiple mechanisms by which filaggrin deficiency contributes to atopic disease remain incompletely understood 5 .
We have optimised a skin organoid model, with dermal and epidermal compartments cultured using donor-matched primary cells, for functional assessments and global mass spectrometry proteomic analysis. The work aims to investigate in more detail the effect of FLG siRNA-mediated knockdown on one cell type -the keratinocyte -to increase understanding of the filaggrin-deficient phenotype and to further define molecular mechanisms predisposing to atopic skin inflammation.
Methods

Source of primary human cells
Primary keratinocytes and primary fibroblasts were isolated from human skin tissue samples obtained, with written informed consent and Ethical Committee approval (East of Scotland Research Ethics Service reference 17/ES/0130 renewal 12/ ES/0083) under governance of the Tayside Biorepository. Surgical surplus samples of clinically normal skin from four adult donors (all females aged 29-65 years; one abdominal and three breast skin reductions) were used for the organoid cultures. Similar samples (n=5) were used for independent biological replicates to test for reproducibility of the functional effects of FLG knockdown.
Organoid culture methods Primary keratinocytes and dermal fibroblasts were isolated from human skin by sequential trypsin EDTA and collagenase D digestion 21 . Using our previously reported methods 12 , the keratinocytes were co-cultured with mitomycin C inactivated 3T3 feeder cells in RM media (3:1 DMEM : Hams F12, 10% FCS, 0.4µg/ml hydrocortisone, 5µg/ml insulin, 10ng/ml EGF, 5µg/ml transferrin, 8.4ng/ml cholera toxin and 13ng/ml liothyronine) (Sigma Aldrich, Gillingham, Dorset, UK) 22 . Epidermal growth factor (EGF) was omitted for the first day of culture. The fibroblasts were cultured in DMEM supplemented with 10% FCS under standard conditions. Fibrin gel dermal equivalents 12 were prepared using 0.5ml fibrinogen (35 mg/ml in NaCl) (Sigma Aldrich, Gillingham, Dorset, UK) and 0.5ml thrombin (3U/ml in 2 mM CaCl 2 / 1.1% NaCl) (Sigma Aldrich, Gillingham, Dorset, UK) combined on ice, with 200,000 fibroblasts and aprotinin (0.1 U/ml) (Sigma Aldrich, Gillingham, Dorset, UK) then transferred to a 12-well plate. After 30 minutes incubation at 37°C, the gels were covered in medium (DMEM, 10% FCS, 0.1 U/ml Aprotinin) and cultured overnight (day 1). On day 2, the medium was replaced with RM excluding EGF, 0.1U/ml aprotinin and 2 × 10 6 suspended keratinocytes. Culture medium was refreshed daily on days 3 and 4 using RM containing 0.1ng/ml EGF and 0.1U/ml aprotinin. On day 5 the gels were carefully removed from wells and lifted onto custom-made steel grids lined with nylon gauze (Millipore, Livingston, Scotland, UK). RM medium supplemented with 0.1ng/ml EGF and 0.1U/ml aprotinin was added up to the base of the dermal equivalent so that the epidermis remained at the air-liquid interface. Medium was refreshed on alternate day sand the cultures were used for analysis up to day 12 (representing three, five and seven days after lifting to the air-liquid interface).
A diagrammatic summary of the process of skin organoid culture is shown in Figure 1 .
Epidermis was separated from the fibrin gel using hypertonic saline-induced split (4 hours, 1M NaCl, 4°C) to obtain a keratinocyte-only tissue sample for biochemical analyses.
FLG genotyping DNA was extracted from donor skin samples using standard techniques and genotyping was performed for the four most prevalent loss-of-function mutations in FLG in this white European population (R501X, 2282del4, R2447X and S3247X) 23 using validated KASP TM technology (LGC Genomics, Hoddesdon, Hertfordshire, UK), as previously reported 4,24 . Briefly, KASP TM SNP genotyping consists of two competitive, allelespecific forward primers and one common reverse primer.
Each forward primer incorporates an additional tail sequence that corresponds with one of two universal FRET (fluorescent resonance energy transfer) cassettes (FAM and HEX). ROX™ passive reference dye, Taq polymerase, free nucleotides and MgCl2 in an optimised buffer solution make up the reaction master mix.
siRNA mediated knockdown
Keratinocytes were reverse transfected immediately prior to inclusion in the organoid cultures using RNAiMax transfection reagent (Life Technologies, Carlsbad, California, USA) according to manufacturer's instructions. Briefly, siRNA complexes were formed in OPTIMEM medium (20uM siRNA, 5µl
RNAiMAX) and following 20 minutes incubation, combined with 2 × 10 6 suspended normal human keratinocytes and transferred to the pre-prepared dermal substrate. A pool of four siRNA duplexes was used [FLG: LQ-021718-00-0002, Control: ON-TARGETplus non-targeting siRNA #4 D.001810-04-20] (Dharmacon, Lafayette, Colorado, USA).
Quantitative PCR
RNA was extracted from organoid epidermis using the Directzol RNA kit (R2071, Zymo Research, Irvine, California, USA) following homogenisation in RNA-Bee (CS-104B, Amsbio, Abingdon, Oxfordhire, UK) using the TissueLyser LT (Qiagen, Manchester, UK) 5 mins at 50 Hz. cDNA was prepared 
Western blotting
Organoid epidermis was homogenized in RIPA buffer (Cell Signalling Technologies, London, UK) using the TissueLyser LT (Qiagen, Manchester, UK) 5 mins at 50 Hz. Protein lysates were normalized by Pierce BCA assay (23225, Thermo Fisher, Waltham, Massachussets, USA) and resolved under reducing conditions using the NuPage® gel electrophoresis system (Life Technologies, Carlsbad, California, USA). Primary antibodies (monoclonal mouse filaggrin [RRID: AB_1122916, catalogue # sc66192, Santa Cruz Biotechnology, Texas, USA] and monoclonal mouse GAPDH [RRID: AB_2756824, catalogue # 97166, Cell Signalling Technologies, Boston, USA]) were prepared in 5% bovine serum albumin (BSA) and incubated overnight at 4°C with agitation. Immunoblots were developed using either goat anti rabbit (P0448, RRID: AB_2617138) or goat anti mouse (P0447, RRID: AB_2617137) peroxidase conjugated secondary antibodies (DAKO, Glostrup, Denmark, 1:5000) in combination with chemiluminescent HRP substrate (Immobilon, Millipore, Billerica, Massachussets, USA) onto photographic film. Densitometry was performed using Fuji ImageJ (May 2017).
Structural assessments (i) Histology
Formalin-fixed, paraffin embedded full thickness organoids were sectioned and stained using haematoxylin and eosin and imaged using Visiscope LT384P (VWR International, Lutterworth, UK).
(ii) Transmission electron microscopy (TEM)
Organoid skin samples were fixed in 4% paraformaldehyde, 2.5% gluteraldehyde in 0.1M sodium cacodylate buffer (pH 7.2) for one hour then cut into small pieces, washed in buffer and post-fixed in 1% osmium tetroxide in cacodylate buffer for one hour or 1% ruthenium tetroxide in cacodylate buffer for one hour. The pieces were dehydrated through alcohol series, into propylene oxide and embedded in Durcupan resin. Ultrathin sections were stained with 3% aqueous uranyl acetate and Reynold's lead citrate and examined on a JEOL 1200EX electron microscope. TEM images were collected on a SIS Megaview III camera.
Functional assessments (i) Trans-epidermal water loss (TEWL)
Organoid cultures were equilibrated at room temperature and atmospheric conditions for 30 minutes before TEWL was measured at two locations on the epidermal surface using an Aquaflux AF200 instrument (Biox Systems Ltd, London, UK) with a closed chamber and a custom (5mm diameter) probe head. TEWL measurements were taken every second for a minimum of 60 seconds until a stable reading, as determined by the software, was obtained. TEWL directly measures water evaporation from the skin surface but it may be considered as a measurement of 'inside-outside' barrier function 25 .
(ii) Capacitance To inform the interpretation of TEWL, we measured electrical capacitance; this is directly proportional to water content of the uppermost 10-20µm of tissue. Organoid cultures were equilibrated at room temperature and atmospheric conditions for 30 minutes prior to measurement of epidermal surface capacitance, using a Corneometer TM and multiprobe adapter (CM825 and MPA2, Courage and Khazaka, Cologne, Germany). Three measurements were recorded from each organoid and the mean was calculated.
(iii) Fluorescent dye penetration 50µl of 1mM lucifer yellow dye (Sigma Aldrich) was added to the epidermal surface of the organoid and incubated at 37°C for 4 hours. Metal cloning rings were used to control uniform dosing on the epidermal surface. The lucifer yellow was removed and the organoids washed in PBS before formalin fix-paraffin embedding under standard conditions. 4µM sections were deparaffinized, counterstained with DAPI (1µg/ml for 10 mins) (Life Technologies, Carlsbad, California, USA) and imaged by confocal Zeiss LSM710 microscope. Quantification of dye penetration in the upper dermis (average intensity in upper 40µm) was performed using Zeiss Zen Blue lite version 2.3 software and compared using paired t-tests. Dye penetration represents a measurement of the 'outside-inside' barrier function.
Mass spectrometry proteomic analysis
Frozen organoid epidermal samples were ground on dry ice, solubilized in 200µl of Cellular and Organelle Membrane Solubilizing Reagent (C0356-4BTL, also called Protein Extraction Reagent Type 4, Sigma-Aldrich, Gillingham, Dorset, UK), 7.0 M urea, 2.0 M thiourea, 40 mM Trizma® base (Sigma Aldrich, Gillingham, Dorset, UK) and 1.0% C7BzO, pH 10.4 buffer with protease inhibitors. The lysate was acetone precipitated for 1 hour at -20°C and spun for 20 mins at 2°C at 15,000 rpm. The pellet was re-suspended in 200µl of 50mM ammonium bicarbonate. 100µl was taken for in-solution digest. 22µl of dithiothreitol was added and samples heated to 50°C for 15mins. 24µl of iodoacetamide was added and the samples incubated at 22°C for 30 mins. 1µl of RapiGest TM (186001860, Waters, Herts, UK) was added, followed by 2.5µl of trypsin, for a 12-hour digest. A further 1µl trypsin was added for an additional 4-hour digest. The peptide samples were fractionated into 24 fractions with high pH Reversed Phase C18 chromatography, run on a Q Exactive Classic or Plus for 160 mins and the top 15 ions selected for sequencing. Mass spectrometry resolution was 70,000 and tandem mass spectrometry (MS/MS) resolution 17,500. Data were processed using MaxQuant (v1.6.0.13) and Human UniProt Database (Dec 2017) with a protein and peptide false discovery rate of 0.01.
Proteins identified as contaminants (trypsin and other lab originating proteins) and contained within the MaxQuant database were removed. To account for the possibility of keratin as a contaminant, we analysed the blank runs for keratin peptide intensity and subtracted this from the measured keratin intensities. A reversed database (i.e. scrambled protein sequences) was used to identify false positives and these were also removed.
Total intensities of the samples were normalized to total protein abundance, with adjustment to the lowest total protein yield. All samples were run in quadruplicate and reproducibility was assessed by Pearson correlation.
Mass spectrometry lipidomic analysis
Organoid samples were sonicated in phosphate buffered saline (pH7.4) and then extracted according to the method of Folch et al. 26 . The samples were analysed by liquid chromatographymass spectrometry (LC-MS) on a Thermo Exactive Orbitrap mass spectrometer (Thermo Scientific, Hemel Hempsted, UK) coupled to a Thermo Accela 1250 ultra high pressure liquid chromatography (UHPLC) system. Samples were injected on to C18 column (Thermo Hypersil Gold, 2.1 mm x 100 mm, 1.9 µm) and separated using a water/acetonitrile/isopropanol gradient 27 . Ceramide 17:0 (Avanti Polar Lipids, Alabaster, AL, USA) was included as an internal standard. Ion signals corresponding to individual ceramide molecular species were extracted from raw LC-MS data sets. Concentration of ceramide was expressed as pmol/mg after normalisation to mg of wet weight tissue.
Data analysis of qPCR, immunoblotting and functional assessments
Measurements were compared between non-targeting control-treated organoid models and FLG-siRNA-treated models, using paired t-test.
Histological sections of 10 replicate skin organoid experiments were measured using a standardized technique to minimize bias, as follows: three points were measured on each slide, at the right side, middle and left of each sample, across viable cell layers and stratum corneum; measurements were generated using Fuji ImageJ (May 2017) and the mean of the three measurements calculated.
Proteomic data analysis
The total intensities of the samples were normalised to total protein abundance, with adjustment to the lowest total protein yield. Fold change in protein expression (non-targeting control/FLG knockdown) was visualised as a volcano plot, using R/ggplot2 (version 3.3.1) for human proteins detected in all four of the replicate experiments with log 10 transformation and paired t-test for significance. Because of the burden of multiple testing in this large dataset, rather than defining arbitrary thresholds for 'statistical significance', our analyses focussed on changes that showed consistency across the biological replicate experiments. Approximately 1000 of the >8000 proteins were selected as showing consistently increased or decreased abundance, defined as follows:
Proteins were considered to be reduced in abundance if they showed a reduction in all four biological replicate experiments comparing FLG-knockdown organoid samples to matched non-targeting controls and fold-change ≤0.5 in three or four out of four of the replicates and reduced to undetectable levels of protein in a maximum of two replicates.
Proteins were considered to be increased in abundance if they showed an increase in all four biological replicate experiments comparing FLG-knockdown organoid samples to matched controls treated with non-targeting controls and fold-change ≥1.2 in three or four out of four of the replicates. This magnitude of fold-change was used to define up-regulated proteins to capture a sufficient number (>300 proteins) to allow pathway analysis. The groups of up-regulated and down-regulated proteins were each assessed using gene ontology and network analysis in STRING, version 11 28 and pathway prediction using the Reactome Knowledgebase, version 68 29 .
Lipidomic data analysis
Fold-change in ceramide and omega-hydroxy ceramide species were compared between the FLG knockdown organoids and matched control samples in five biological replicate experiments.
Results
All samples are wild-type for the prevalent FLG null mutations and filaggrin shows knockdown at mRNA and protein level Genotyping of DNA from tissue samples from the four skin donors did not detect any of the prevalent FLG null mutations 30 ; this does not, however, exclude the possibility of rare (<0.01 allele frequency) null mutations.
FLG knockdown in the skin organoids persisted to day 10 after siRNA transfection, as demonstrated by qPCR ( Figure 2 ) and western blotting ( Figure 3 ).
FLG knockdown results in morphological changes in the epidermis
Histological examination confirmed a reduction of the granular layer, in keeping with a reduction in profilaggrin ( Figure 4A ). There was also a slight reduction in thickness of the stratum corneum (fold change 0.83 +/-0.05 (mean +/-SEM), but no difference in thickness of the keratinocyte cell layers ( Figure 4B ). Transmission electron microscopy (TEM) of the skin organoid model shows an effective recapitulation of the physiological layers of keratinocyte differentiation within skin, including a mature, multi-layered stratum corneum with corneodesmosomes and a granular layer with keratohyalin granules and desmosomes ( Figure 5A ). TEM of the FLG-knockdown organoid shows a similarly mature epidermis, but the stratum corneum has fewer layers and the granular layer contains keratohyalin granules that are generally smaller and less numerous than in the control organoid ( Figure 5B ).
FLG knockdown shows some evidence of a barrier defect in the immature organoids but no functional effect on skin barrier in the mature organoid model The organoid model described here shows progressive development of skin barrier function after lifting to the air-liquid interface: there is a progressive reduction in TEWL ( Figure 6 ), progressive reduction in capacitance (Figure 7 ) and the hydrophilic dye, lucifer yellow, is excluded from the epidermis by day 7 in both the control and FLG-knockdown organoids (Figure 8 ).
Results from five biological replicate experiments showed there was no difference in the mean TEWL ( Figure 6 ), or mean capacitance measurements (Figure 7) between the mature organoid models with FLG knockdown and donor-matched non-targeting siRNA-treated controls. Capacitance was increased in the immature FLG-knockdown model (day 5 after air-exposure) and lucifer yellow dye was not fully excluded by the stratum corneum in the FLG-knockdown until day 7 (Figure 8 ). However, this delay in maturation of the 'outside-to-inside' barrier function was not consistently demonstrated in all biological replicates. Mass spectrometry proteomic analysis identifies over 8000 protein species per sample After removal of contaminants and false positive results, >8000 proteins were identified in each epidermal sample. The proteomic data have been deposited to the ProteomeXchange Consortium via the PRIDE 31 partner repository with dataset identifier PXD014875. Quality control analysis confirmed that similar distributions of proteins were identified in each experiment ( Figure 9A) ; protein extracts were analysed in quadruplicate to test for technical reproducibility and the Pearson correlations were 0.869-0.938 ( Figure 9B ). Fold change ≥ 2× protein expression with nominally significant (p<0.05) difference is visualised as a volcano plot in Figure 10 . 645 of the proteins are identified in STRING and this group showed significant enrichment for interactions (p<1.0e-16) computed by combining the probabilities from the different evidence channels and corrected for the probability of randomly observing an interaction 21 . Gene ontology (GO) analysis in STRING showed evidence for functional enrichment of GOterms including RNA processing (false discovery rate (FDR) 4.40e-11), catalytic activity (FDR 8.59e-08) and intracellular component (FDR 3.88e-26). A list of the 10 most significant GO analysis results in each of the GO domains is shown in Table 1 (see Underlying data) 32 .
Pathway analysis of down-regulated proteins identifies themes including RNA metabolism, adaptive immunity and axon guidance Reactome detected 39 pathways in this set of proteins ( Table 2 , Underlying data) 33 . Descriptions include: metabolism of RNA (including 67 out of the 652 genes in this pathway, 
Down-regulated proteins indicate molecular mechanisms of relevance to atopic eczema
Manual searching of the list of down-regulated proteins identified several of specific interest based on a priori knowledge of eczema pathomechanisms. These highlight several putative therapeutic targets: the aryl hydrocarbon receptor plays a role in signalling pathways for skin barrier repair 22 and has been proposed as a therapeutic target for the treatment of skin inflammation 34 ; caspase 14 plays a role in filaggrin processing 35 and is required for epidermal protection against water loss and UVB-induced damage 36 ; dermokine is a soluble regulator of keratinocyte differentiation 37 ; sequence similarity to a murine protein (UniProtKB:Q8R1R3) indicates that StAR-related lipid transfer protein 7 may play a role in protecting mucosal tissues from exaggerated allergic responses; a reduction in the cytokine TGF-beta 1 may predispose to atopic eczema 38 ; and loss-of-function mutations in CYP4F22 cause lamellar ichthyosis 39 , suggesting that a reduction in CYP4F22 protein expression may contribute to the ichthyotic phenotype observed in ichthyosis vulgaris and atopic skin. 374 proteins are identified in STRING and the group showed significant enrichment for interactions (p<1.0e-16). GO analysis revealed enrichment of terms including translation (FDR 4.12e-19), RNA binding (FDR 9.77e-12) and cytoplasmic part (FDR 9.64-36). A list of the 10 most significant GO analysis results in each of the GO domains is shown in Table 3 (see Underlying data) 40 .
Pathway analysis of up-regulated proteins identifies themes including translation, innate and adaptive immunity and axon guidance
Reactome detected 113 pathways in this set of proteins with FDR p<0.05 (Table 4 , Underlying data) 41 . Descriptions include: Translation (including 44 out of the 288 genes in this pathway, FDR 1.17e-21); innate immune system (47/1012 genes in pathway, FDR 9.90e-7); cytokine signalling in immune system (32/654 genes in pathway, FDR 5.16e-05); and axon guidance (40/541, FDR 4.69e-11).
Up-regulated proteins indicate molecular mechanisms of relevance to atopic eczema
Manual searching of the list of up-regulated proteins identified several of relevance to atopic eczema, including: STAT1, an intracellular signalling molecule that shows increased expression in atopic eczema, and as part of the JAK-STAT pathway is targeted by several traditional herbal remedies 42 as well as novel small molecule therapies 43 ; carbonic anhydrase 2, which is increased in skin in a variety of forms of eczema 44 ; and FK binding protein, which binds to tacrolimus, an established topical treatment for atopic eczema.
The type I keratins 10, 16 and 17 each show increased expression in the FLG-siRNA-treated organoid models with mean fold change 1.7, 1.3 and 1.3, respectively. Keratin 10 is an intermediate filament protein of structural importance in the skin; keratin 16 is an epidermis-specific keratin that plays a role in innate immunity in response to skin barrier breach 45 ; keratin 17 is expressed in epidermal appendages, including the hair follicle.
Finally, it is noteworthy that GAPDH, which is often considered to be a stable 'housekeeping' gene, is in the dataset of consistently up-regulated proteins. However, in the context of this work, filaggrin knockdown is clearly apparent at a greater magnitude than the more subtle change in GAPDH (Figure 3 ).
Epidermal ceramide content shows no significant difference in FLG-knockdown organoids compared with controls
Ceramide and omega-hydroxy ceramide species in five biological replicate experiments showed no consistent difference between the FLG knockdown organoids and matched control samples (Figure 11 ).
Discussion
The functional and biochemical analyses of a filaggrin-deficient skin model have provided findings that are consistent with our and others' previous analyses in vitro 19 and in vivo 46 . We have included both epidermal and dermal compartments in this model (to allow for dermal-epidermal cross-talk 47,48 ) and our more detailed proteomic analysis has revealed additional evidence of molecular mechanisms with relevance to atopic skin. Analysis of the immature organoid identified a delay in epidermal maturation following FLG knockdown, but the lack of a replicable functional effect in our model, when mature, reflects previous reports in which epidermal equivalents created from FLG-null keratinocytes do not show impairment in barrier function 20 . This is in keeping with the observation that FLGnull mutations are not fully penetrant with respect to ichthyosis vulgaris or atopic eczema 16, 49 .
The proteomic analysis reveals evidence of keratinocyteimmune signalling, an important component of the immunological barrier that may be overlooked in tissue with multiple different cell types. The predicted pathways entitled 'innate immunity' and 'adaptive immunity' included proteins showing both increased and decreased expression ( Table 2 and Table 4 , Underlying data) 33,41 . This immune dysregulation is likely to contribute to the predisposition to infection and inflammation observed in filaggrin-deficient skin in vivo: filaggrin-deficient patients show increased viral infection of the skin 50 and increased incidence of irritant 51,52 and allergic contact dermatitis 53 . The regulation of innate and adaptive immune pathways within keratinocytes (in addition to cells of the haematopoietic lineage) may therefore represent a worthwhile target for future therapeutic interventions.
The lack of effect of FLG knockdown on the ceramide content in the model epidermis is also consistent with previously reported findings in vitro 54, 55 and in vivo 56 . We did not analyse in detail the other epidermal lipids and therefore we cannot comment on whether there were relevant changes. Differences in lamellar body structure 57 have been reported in FLG-mutant skin biopsies but this was not clearly observed in the organoid model. However, ultrastructural examination of the model stratum corneum did reveal abnormalities in the lamellar bilayer structure and less prominent corneodesmosomes ( Figure 5 ), as previously reported in vivo 57 . It is also noteworthy that pathway analysis in Reactome identified the terms 'metabolism of lipids' and 'phospholipid metabolism' from the group of consistently down-regulated proteins (Table 4 , Underlying data) 41 .
The most significant themes identified in the groups of proteins showing increased expression upon FLG knockdown relate to RNA binding and translation; this is in contrast to RNA metabolism and RNA processing, which are demonstrated in the proteins showing decreased expression. The functional significance of this increase in transcriptional and translational activity cannot be determined from the gene ontology and pathway analysis. We may hypothesise that it reflects the increased 'stress' response, as we have previously observed in FLG genotype-stratified transcriptome analysis of atopic skin biopsies 18 and/or the activation of innate and adaptive immune mechanisms.
It is tempting to speculate that the increased expression of keratins 10 and 16 may contribute to palmar hyperlinearity and keratin 17 may contribute to keratosis pilaris. These are characteristic features of ichthyosis vulgaris but their pathogenesis has not yet been explained as a direct result of filaggrin haploinsufficiency 16,58 . Several of the proteins showing reduced expression relate to aspects of differentiation, including filaggrin itself, and caspase 14 which plays a role in the terminal degradation of filaggrin 35 . The aryl hydrocarbon receptor (AhR) is a ligandactivated transcription factor that responds to multiple different environmental and metabolic stimuli to control transcriptional pathways of relevance to atopic eczema, including immunity and differentiation 59 . Activation of AhR reduces skin inflammation 60 and enhances barrier repair 61 ; therefore, a reduction in AhR expression in the FLG knockdown organoid would be anticipated to increase the eczema diathesis by opposing these effects. AKT1 activity is known to be reduced in atopic skin, leading to an alteration in protease expression and reduced filaggrin expression and processing 62 . This mechanism may further exacerbate the filaggrin deficiency in our FLG knockdown organoid. Dermokine acts as a soluble regulator of keratinocyte differentiation and mice deficient in the epidermal dermokines (beta and gamma isoforms) show defective cornification 63 . Transforming growth factor (TGF) beta-1 is a multifunctional protein: it regulates the growth and differentiation of multiple cell types, including keratinocytes and it can promote either Th17 or T-regulatory cell lineage differentiation in a concentration-dependent manner; it appears to have an immunosuppressive effect in atopic disease since a geneticallydetermined lower production of TGF-beta-1 is associated with increased risk of atopic dermatitis 38 .
The Reactome term 'axon guidance' was detected in proteins showing increased and decreased expression. It has long been recognised that there is an increase in the density of sensory neurons in eczematous skin 64 and nerve growth factor expression is upregulated in the keratinocytes of patients with atopic eczema 65 . Therefore, dysregulation of axon guidance may be of relevance to the pruritus that is so characteristic of atopic eczema and contributes substantially to the morbidity of this condition 3 . Antagonists of transient receptor potential vanilloid subfamily member 1 (TRPV1), expressed on sensory nerves and keratinocytes, are now being investigated for the control of pruritus 66,67 .
Taken together, our data demonstrate that filaggrin haploinsufficiency leads to abnormalities in both structural and immune features within the keratinocyte compartment of the epidermis. Keratinocytes display immune activity, producing multiple cytokines and chemokines in addition to their roles in innate immunity 68, 69 . Together with the evidence of dysregulation in axon guidance, these findings indicate that patients with filaggrin deficiency -either haploinsufficiency or a reduction in filaggrin expression that occurs secondary to atopic inflammation 70may derive clinical benefit from future therapies targeting keratinocyte-immune crosstalk mechanisms and neurogenic pruritus. The skin organoid model described here represents a valuable opportunity to study genetic effects on keratinocytes in relative isolation. However, the lack of other cell types (notably T cells, B cells, dermal dendritic cells and innate lymphoid cells), the absence of complex dermal structures (including neurons and blood vessels) and skin appendages (for example hair follicles, sweat and sebaceous glands) is also a limitation in that it precludes assessment of the complex interactions that are likely to occur between different tissue compartments in skin.
In conclusion, we share these experimental results in detailed form, because of the additional insight provided by this in vitro analysis of filaggrin deficiency in a skin organoid model; our findings compliment and extend previous work in vitro and in vivo. The analyses have re-emphasised the role of keratinocyte-specific mechanisms in contributing to immune and neurological as well as structural aspects of skin barrier function and offer new insight into molecular mechanisms for the ichthyosis vulgaris phenotype. Ceramide analysis has been carried out in the model epidermis. Performing ceramide analysis in the isolated stratum corneum might have been more relevant.
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© 2019 Rajan N. This is an open access peer review report distributed under the terms of the Creative Commons , which permits unrestricted use, distribution, and reproduction in any medium, provided the original Attribution License work is properly cited. In this study, primary keratinocytes from 4 female filaggrin wild-type genotyped individuals were subject to siRNA kd and a nontargeting siRNA control. These were grown in a skin equivalent model with FLG matched donor fibroblasts, and then keratinocytes alone were harvested after the model had been in at the air liquid interface for 7 days. This was used to carry out proteomic and lipidomic analysis. Additional samples were used for validation work.
Neil Rajan
The work has been meticulously described in the methods and is an exemplar for human primary keratinocyte research. Filaggrin knockdown was demonstrated at the transcriptomic and protein level, and is evident in the mass spec data across all samples. A phenotype is seen on TEM and is elegantly presented Fig 5. Barrier function as assessed by TEWL and dye penetration is not impaired following FLG knockdown at Day 7, which is consistent with prior reports using skin equivalent models.
The key findings are the differentially expressed proteins in this novel model, and unlike prior skin equivalent papers, here dermal fibroblasts are used, allowing for better modelling of human skin where cross talk happens. Notably, lipidomic studies did not show a difference in epidermal ceramides.
Comments:
The authors highlight the proteins that have relevance to the known pathogenetic mechanisms of eczema. It would be helpful to emphasise the novel findings detected in this model compared to the prior proteomic analysis published on filaggrin knockdown keratinocytes (Elias ., 2017 ), et al as that model did not include matched donor fibroblasts. Table 2 presents Reactome data and highlights Axon guidance, and it would be helpful to see this in the context of the other pathways described. I would favour this being included in the PDF, rather than Fig 9, which may be moved to supplementary data.
The volcano plot (Fig 10) is of interest, but more data could be presented here, for example, the 7 points which are log2 fold change >+5 could be identified to make this more informative for the reader. I am uncertain if the colour scheme with p value cut offs is helpful; the authors carefully justify using selected fold change thresholds in the methods section over arbitrary thresholds that are p-value driven and this depiction is at odds with this.
Could the title be improved to reflect the more complete nature of this skin equivalent model that incorporates fibroblasts? Also, how were the three elements "increased transcriptional-translational activity, keratinocyte-immune crosstalk and disordered axon guidance" selected or prioritised from the list of Reactome findings?
There is a minor typographical error on page 3. "Medium was refreshed on alternate day the cultures sand 1 1.
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been used for proteomics studies. The proteomics analysis provides some insight into the molecular mechanisms underlying the effect of filaggrin on keratinocyte function. The advantage of this system is the focus on the keratinocyte phenotype. The disadvantage is the lack of the influence of other cell types that are important for Atopic Dermatitis pathogenesis. Overall, this is an interesting study, although there is no functional follow-up of any of the differentially expressed proteins. In addition, the statistical analysis requires improvement.
Specific comments:
The filaggrin knock-down at the RNA level was only approximately 50%, whereas the knock-down at the protein levels seems more robust. How do the authors explain this inconsistency? Why are there no error bars in Fig. 2 NT-siRNA? The data should be confirmed by immunostaining of the cultures for filaggrin. Staining of the cultures for loricrin would be helpful to confirm abnormalities in the granular layer.
It is impossible to see obvious differences in Lucifer yellow penetration and there is also no statistically significant difference. This should be expressed more carefully.
The proteomics data provide a very important resource. It would have been helpful to show the validation of some of the data using independent samples and another method, e.g. Western blot and/or immunohistochemistry. This would be easy for selected proteins, such as the different keratins.
A comparison of the data with available transcriptomics data from AD patients would be interesting.
For the proteomics analyses, it is not clear how the false discovery rate was exactly determined (scrambled or reversed database?) and how false positives were removed. This requires clarification.
Statistical analysis to identify proteins with differential abundance between conditions lacks stringency and appears asymmetric with regard to positive and negative effect sizes. Lack of statistically significant hits upon multiple testing correction is a common problem with proteomics datasets. Which multiple testing correction algorithm was applied? Bonferroni or Benjamini-Hochberg? Did the authors try e.g. a limma moderated t-test that has proven useful for proteomics data? Even without multiple testing correction, a statistical test appears more suitable than selecting differentially abundant proteins only based on consistency between comparisons/experiments. Moreover, the authors apply a cut-off of 2-fold (0.5) to identify proteins with lower abundance upon filaggrin knockdown and of 1.2-fold (1.2) for those with higher abundance in this condition. It appears this skewed effect size has been selected aiming at equalizing hit numbers for pathway enrichment. This should be reconsidered. The terms 'ratio' and 'fold-change' are not used properly, since the authors report actual ratios as fold-changes, e.g. a ratio of 0.5 would correspond to a fold-change of -2 and of 2 to a fold change of +2. Since identifying proteins with statistically significantly differential abundance between conditions is crucial, also for follow-up data analysis, the authors should re-evaluate this part of the study with help of an expert in proteomics statistics.
Is the work clearly and accurately presented and does it cite the current literature? Yes
Is the study design appropriate and is the work technically sound?
